ASHLEY MATHAI: Open Payments
NPI 1306330295 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,336 in 18 payments from 6 companies in 2025. Trend: 2023 $854 · 2024 $1,323 · 2025 $2,336
Food & beverage: $2,336
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $739 |
| E.R. Squibb & Sons, L.L.C. | 4 | $501 |
| ABBVIE INC. | 3 | $434 |
| Neurocrine BioSciences, Inc. | 2 | $305 |
| PFIZER INC. | 2 | $239 |
| Axsome Therapeutics, Inc. | 1 | $117 |
Products named: COBENFY, AUSTEDO XR, VRAYLAR, INGREZZA, UZEDY, NURTEC ODT, Symbravo.
Industry payments across NY — which companies pay providers there.
